Detection and Automatic Segmentation of Liver Nodules in Patients With Colorectal Adenocarcinoma
NCT ID: NCT04834596
Last Updated: 2021-04-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
300 participants
OBSERVATIONAL
2021-05-02
2022-05-02
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Prospective Phase II Trial on Prophylactic Perihepatic Lymphadenectomy in Patients With Colorectal Cancer With Liver Metastasis
NCT01565811
Artificial Intelligence Diagnosis of Different Histopathological Growth Patterns of Colorectal Cancer Liver Metastasis
NCT07088393
Study on the No.253 Lymph Node Metastasis Patterns in Left-Sided Colon and Rectal Cancer
NCT06135571
Comparison of Triphasic CT, PET and MR Tumour With Pathological Findings in Colorectal Cancer Liver Metastases
NCT00242086
Evaluation of Diffusion Weighted Imaging -MRI in Patients With Resectable Liver Metastases From Colorectal Cancer
NCT02355353
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
300 hepatic scanners will be analysed.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
patients without hepatic metastases
hepatic scanner of 100 patients with colorectal cancer without hepatic metastases will be analysed
retrospectives analysis on hepatic scanner
hepatic scanner will be analysed by two radiologist and by the software
patients with synchronous hepatic metastases
hepatic scanner of 100 patients with colorectal cancer with synchronous hepatic metastases will be analysed
retrospectives analysis on hepatic scanner
hepatic scanner will be analysed by two radiologist and by the software
patients with metachronous hepatic metastases
hepatic scanner of 100 patients with colorectal cancer with metachronous hepatic metastases will be analysed
retrospectives analysis on hepatic scanner
hepatic scanner will be analysed by two radiologist and by the software
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
retrospectives analysis on hepatic scanner
hepatic scanner will be analysed by two radiologist and by the software
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Availability of imaging by injected abdominal scanner including at least one portal phase
* Age over 18
Exclusion Criteria
* Imaging follow-up \<12 months
* Non-interpretable scanner (artefact, injection quality, etc.)
* Patients with more than 10 liver metastases
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Angers
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
UHAngers
Angers, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2021 OOPS
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.